Examining how immune-inflammatory biomarkers affect PTSD treatment response

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the role of immune-inflammatory biomarkers and their interaction with the oxytocin system in influencing treatment responsiveness in patients with posttraumatic stress disorder (PTSD). It aims to recruit 100 participants from the Shalvata Mental Health Center who will undergo psychotherapy for 12 weeks. The study will assess how these biological factors may impact the development of PTSD and the effectiveness of psychotherapy. By understanding these interactions, the research seeks to identify predictors of treatment outcomes for PTSD patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Minimum score of 33 on the PTSD symptoms questionnaire (PCL-5).
* Anticipated 12-24 psychotherapy sessions.

Exclusion Criteria:

* Psychotic episode.
* Female patients: pregnancy or breastfeeding (according to self-report).

Where it's running

• Shalvata Mental health Center
  Hod HaSharon, Israel Recruiting

Study contacts

• Study coordinator: Omer Sedoff, MA
• Email: omerse@clalit.org.il
• Phone: 97297478555

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Reboxetine plus Ritalin vs Dog-Assisted Therapy for PTSD

  This study tests whether a drug combo of reboxetine and methylphenidate works better than dog-assisted therapy for people with PTSD.

  Recruiting Phase 2 University of Haifa · Haifa · NCT07771530

• Self-Help CPT with WoVeN Peer Support for Women Veterans with PTSD

  This study tests a self-help Cognitive Processing Therapy and a WoVeN peer-support program, alone and together, to see if they improve PTSD symptoms and well-being for women veterans.

  Recruiting Boston University · Boston, Massachusetts · NCT07250061

• Adaptive, personalized PTSD care for veterans

  This program will try different therapy sequences plus optional text-message homework reminders to see if switching treatments or sending prompts helps veterans with PTSD who aren't improving or are missing between-session homework.

  Recruiting at 3 sites The University of Texas Health Science Center at San Antonio · Augusta, Georgia and 3 other locations · NCT07176273

• Multi‑Mode Cognitive Processing Therapy for adults with PTSD

  This program will try a multi‑mode form of Cognitive Processing Therapy to reduce PTSD symptoms and improve sleep and mood in adults aged 20–65 with PTSD.

  Recruiting Far Eastern Memorial Hospital · New Taipei City, Banqiao District · NCT07105345

• Improving thinking, daily functioning, mood, and sleep after mild traumatic brain injury and PTSD

  This project will test whether adding morning bright light therapy to compensatory cognitive training helps post-9/11 Veterans with mild traumatic brain injury and PTSD think, function, and sleep better compared with a neutral ion generator.

  Recruiting at 2 sites VA Office of Research and Development · San Diego, California and 1 other locations · NCT07055633

• Combined MDMA and psilocybin treatment for Veterans with PTSD

  This trial tests whether giving MDMA followed 30 minutes later by psilocybin can be safely used to reduce symptoms in military veterans with long-standing PTSD.

  Recruiting Phase 1 Johns Hopkins University · Baltimore, Maryland · NCT06989957

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.